The probability of BC-PDM response to PTX was doubled by increased GATA3 (OR = 2.34, 95% CI: 1.24–6.2) and NF1 (OR = 2.15, 95% CI: 1.25–4.5) expression and decreased levels of Vimentin-pSer56 (OR = 0.72, 95% CI: 0.51–0.93) (Figure S4F; Table S10; p < 0.01 [Wald, LRT]). Here, GATA3 is linked to breast cancer.